Hôpital raymond Poincaré
Garches, Île-de-France Region, 92380, France
NCT Number: NCT03459300
7 to 14 days actimetry recording in order to exclude sleep deprivation just before hospitalisation for differential diagnosis of hypersomnia
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Garches, Île-de-France Region, 92380, France
This is an observational study
Urine drug screening will also be performe
The suty includes four centers in France
The study duration is of one year
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 7-14 days before hospitalisation
mean total sleep time as measured by actimetry durind the 7 - 14 days before hospitalisation
Centre d'Investigation Clinique et Technologique 805
Other
Importance of Sleep Deprivation in Differential Diagnosis of Primary Hypersomnia in Reference Centers Rare Hypersomnia
Acronym: Actisom
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06404099
COVID-19, Chronic Disease
Durham, North Carolina, United States
View Trial DetailsNCT00916253
Disorders of Excessive Somnolence, Dyssomnias
Bordeaux, France
View Trial DetailsNCT06531876
Disorders of Excessive Somnolence, Dyssomnias
Fontana, California, United States
View Trial DetailsNCT06404086
COVID-19, Chronic Disease
Phoenix, Arizona, United States
View Trial Details